Mario Lebrun's guest appearances

Mario Lebrun

Biotechnology Focus Podcast

Kirsty Duncan

Michael May

Ted Rogers

Brian Bloom

Andrew Casey

Gordon McCauley

Gail Garland

Bloom Burton

Merus Sintrom

Michael Stopay

Liam Kaufman

Jacqueline Shan

Quark Ventures

Bellus Health

Rory Francis

OwlTail

Mario Lebrun, former BIO Quebec managing director passes away, Mylan introduces three generic drugs for HIV, and Shire Pharma’s Onivide has been approved for metastatic adeno carcinoma of the pancreas. In this week’s Biotechnology Focus Podcast, we observe the passing of Mario Lebrun. The former managing director of BIO Quebec succumbed to cancer earlier this month. In other news, Mylan of the Netherlands announced it is rolling out in Canada, three generic drugs for the treating HIV. Shire Pharma Canada ULC said its injectable drug Onivyde has been approved for the treatment of metastatic adeno carcinoma of the pancreas. The read the whole stories, please click on the links below:  MARIO LEBRUN FORMER BIO QUEBEC MANAGING DIRECTOR PASSES AWAY MYLAN INTRODUCES THREE HIV DRUGS IN CANADA ONIVYDE APPROVED FOR TREATMENT OF PANCREATIC CANCER: SHIRE PHARMA 

Mario Lebrun, former BIO Quebec managing director passes away, Mylan introduces three generic drugs for HIV, and Shire Pharma’s Onivide has been approved for metastatic adeno carcinoma of the pancreas. In this week’s Biotechnology Focus Podcast, we observe the passing of Mario Lebrun. The former managing director of BIO Quebec succumbed to cancer earlier this month. In other news, Mylan of the Netherlands announced it is rolling out in Canada, three generic drugs for the treating HIV. Shire Pharma Canada ULC said its injectable drug Onivyde has been approved for the treatment of metastatic adeno carcinoma of the pancreas. The read the whole stories, please click on the links below: <ul> <li><a href="https://biotechnologyfocus.ca/mario-lebrun-former-bio-quebec-managing-director-passes-away/" rel="noopener nofollow" target="_blank">MARIO LEBRUN FORMER BIO QUEBEC MANAGING DIRECTOR PASSES AWAY</a></li> <li><a href="https://biotechnologyfocus.ca/mylan-introduces-three-hiv-drugs-in-canada/" rel="noopener nofollow" target="_blank">MYLAN INTRODUCES THREE HIV DRUGS IN CANADA</a></li> <li><a href="https://biotechnologyfocus.ca/onivyde-approved-for-treatment-of-pancreatic-cancer-shire-pharma/" rel="noopener nofollow" target="_blank">ONIVYDE APPROVED FOR TREATMENT OF PANCREATIC CANCER: SHIRE PHARMA</a></li> </ul>

062 | Pancreatic cancer treatment, three HIV drugs, farewell to Mario Lebrun